ORIGINAL RESEARCH
Accepted on 22 Dec 2025
Immune Checkpoint Inhibitor-Related Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Retrospective Analysis of 21 Cases
- 119 views
- Frontiers in Medicine
- Dermatology
- Research Topics
- Exploring Cutaneous Drug-Related and Drug-Associated Adverse Events: From Clinical Insight to Therapeutic Management
Exploring Cutaneous Drug-Related and Drug-Associated Adverse Events: From Clinical Insight to Therapeutic Management
1,047
Total downloads
12k
Total views and downloads
Submit your idea
You will be redirected to our submission process.
Articles
CASE REPORT
Published on 19 Dec 2025
Severe systemic cutaneous adverse reactions following camrelizumab therapy: a case report and literature review
doi 10.3389/fimmu.2025.1714201
- 721 views
CASE REPORT
Published on 18 Dec 2025
Bullous pemphigoid induced by anti-IL-23 monoclonal antibody in a psoriatic patient: a case report
doi 10.3389/fmed.2025.1709423
- 672 views
CASE REPORT
Accepted on 12 Dec 2025
Case Report: Pembrolizumab associated lichen planus in early stage triple negative breast cancer
- 178 views
ORIGINAL RESEARCH
Accepted on 09 Dec 2025
Predictive Value of A Severity-of-Illness Score for Toxic Epidermal Necrolysis (SCORTEN) Factors for In-Hospital Mortality in Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
- 189 views
CASE REPORT
Published on 08 Dec 2025
Case Report: Successful management of high-volume paclitaxel extravasation with hyaluronidase and dry warm compresses
doi 10.3389/fonc.2025.1699608
- 645 views
SYSTEMATIC REVIEW
Accepted on 02 Dec 2025
Construction of a Management and Prevention Program for Targeted Therapy-Induced Hand-Foot Skin Reaction
CASE REPORT
Published on 28 Nov 2025
Case Report: Zinc deficiency as a modifiable risk factor for enfortumab vedotin–induced cutaneous adverse events
doi 10.3389/fonc.2025.1690770
- 633 views
CASE REPORT
Published on 10 Nov 2025
Sweet’s syndrome with Koebner phenomenon triggered by G-CSF as a preleukemic manifestation in a patient with primary myelofibrosis: a case report
doi 10.3389/fmed.2025.1632767
- 1,218 views
ORIGINAL RESEARCH
Published on 03 Nov 2025
Association between oral JAK-1 inhibitors and infection risks in atopic dermatitis: a retrospective analysis of the FAERS database
doi 10.3389/fmed.2025.1694688
- 1,567 views
- 1 citation
ORIGINAL RESEARCH
Published on 13 Oct 2025
Real-world safety of ixekizumab: a disproportionality analysis using the FDA adverse event reporting system and the VigiAccess databases
doi 10.3389/fmed.2025.1652401
- 1,950 views
CASE REPORT
Published on 02 Oct 2025
Psoriasis caused by camrelizumab in a patient with esophageal cancer: a case report
doi 10.3389/fmed.2025.1647297
- 976 views
- 1 citation
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
You will be redirected to our submission process.